These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35747981)

  • 21. Cutibacterium acnes: Much ado about maybe nothing much.
    van Steensel MAM; Goh BC
    Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acne. A review of optimum treatment.
    Sykes NL; Webster GF
    Drugs; 1994 Jul; 48(1):59-70. PubMed ID: 7525195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the use of combination therapies for the treatment of acne vulgaris.
    Leyden JJ
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S200-10. PubMed ID: 12963896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights of Lipid Vesicular and Particulate Carrier Mediated Approach for Acne Management.
    Dudhat S; Singh P; Pimple P
    Curr Drug Deliv; 2022; 20(1):57-74. PubMed ID: 35611775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational therapy for acne vulgaris: an update on topical treatment.
    Leyden JJ; Shalita AR
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):907-15. PubMed ID: 2945846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acne vulgaris. Pathogenesis and treatment.
    Winston MH; Shalita AR
    Pediatr Clin North Am; 1991 Aug; 38(4):889-903. PubMed ID: 1831256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
    Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
    J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocarriers as versatile delivery systems for effective management of acne.
    Patel R; Prabhu P
    Int J Pharm; 2020 Apr; 579():119140. PubMed ID: 32061843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M; Bowe WP; Heughebaert C; Shalita AR
    J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From new findings in acne pathogenesis to new approaches in treatment.
    Gollnick HP
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():1-7. PubMed ID: 26059819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From pathogenesis of acne vulgaris to anti-acne agents.
    Cong TX; Hao D; Wen X; Li XH; He G; Jiang X
    Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
    Kinney MA; Yentzer BA; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern management of acne.
    Cooper AJ; Harris VR
    Med J Aust; 2017 Jan; 206(1):41-45. PubMed ID: 28076744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cosmeceuticals based on Rhealba(®) Oat plantlet extract for the treatment of acne vulgaris.
    Fabbrocini G; Saint Aroman M
    J Eur Acad Dermatol Venereol; 2014 Dec; 28 Suppl 6():1-6. PubMed ID: 25428278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies.
    Thiboutot DM; Gollnick HP
    J Drugs Dermatol; 2006 Sep; 5(8):785-94. PubMed ID: 16989194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.